FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 30 filers reported holding FENNEC PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,613,120 | +83.0% | 272,200 | +59.2% | 0.91% | +215.6% |
| Q2 2020 | $1,428,000 | +1730.8% | 171,000 | +1325.0% | 0.29% | +1820.0% |
| Q4 2019 | $78,000 | -93.4% | 12,000 | -95.9% | 0.02% | -95.8% |
| Q2 2019 | $1,180,000 | -61.4% | 295,000 | -53.2% | 0.36% | -57.4% |
| Q1 2019 | $3,056,000 | -46.8% | 630,000 | -30.0% | 0.85% | -60.5% |
| Q4 2018 | $5,742,000 | -28.2% | 900,000 | -7.7% | 2.14% | +5.4% |
| Q3 2018 | $7,995,000 | -19.0% | 975,000 | +3.2% | 2.03% | -20.3% |
| Q2 2018 | $9,865,000 | -6.6% | 945,000 | +8.2% | 2.55% | -15.4% |
| Q1 2018 | $10,559,000 | +24.4% | 873,000 | +3.1% | 3.02% | +11.1% |
| Q4 2017 | $8,486,000 | – | 846,900 | – | 2.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |